Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000634877 | SCV000756235 | uncertain significance | Holocarboxylase synthetase deficiency | 2021-09-19 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with arginine at codon 505 of the HLCS protein (p.Gly505Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This missense change has been observed in individual(s) with holocarboxylase synthetase deficiency (PMID: 20095979; Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Counsyl | RCV000634877 | SCV000793895 | uncertain significance | Holocarboxylase synthetase deficiency | 2017-09-12 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000634877 | SCV005059686 | likely pathogenic | Holocarboxylase synthetase deficiency | 2024-02-24 | criteria provided, single submitter | clinical testing |